UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular mechanisms regulating the hormone sensitivity of breast cancer

Cancer science, 2014-11, Vol.105 (11), p.1377-1383

2014

Volltextzugriff (PDF)

Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women

PloS one, 2016-12, Vol.11 (12), p.e0168090-e0168090

2016

Volltextzugriff (PDF)

Vimentin as a poor prognostic factor for triple-negative breast cancer

Journal of cancer research and clinical oncology, 2013-05, Vol.139 (5), p.739-746

2013

Volltextzugriff (PDF)

Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer

Clinical breast cancer, 2015-12, Vol.15 (6), p.498-504

2015

Volltextzugriff (PDF)

HB‐EGF orchestrates the complex signals involved in triple‐negative and trastuzumab‐resistant breast cancer

International journal of cancer, 2010-12, Vol.127 (11), p.2707-2717

2010

Volltextzugriff (PDF)

Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer

Breast cancer (Tokyo, Japan), 2014-05, Vol.21 (3), p.341-349

2014

Volltextzugriff (PDF)

The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy

Breast cancer (Tokyo, Japan), 2017-05, Vol.24 (3), p.384-392

2017

Volltextzugriff (PDF)

Trastuzumab and breast cancer: developments and current status

International journal of clinical oncology, 2006-06, Vol.11 (3), p.199-208

2006

Volltextzugriff (PDF)

Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer

Oncotarget, 2018-12, Vol.9 (98), p.37216-37228

2018

Volltextzugriff (PDF)

Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer

Breast cancer (Tokyo, Japan), 2015-09, Vol.22 (5), p.520-528

2015

Volltextzugriff (PDF)

Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer

Breast (Edinburgh), 2016-02, Vol.25, p.62-68

2016

Volltextzugriff (PDF)

Akt is frequently activated in HER2/neu‐positive breast cancers and associated with poor prognosis among hormone‐treated patients

International journal of cancer, 2006-01, Vol.118 (2), p.284-289

2006

Volltextzugriff (PDF)

The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer

Anticancer research, 2018-04, Vol.38 (4), p.2359-2362

2018

Volltextzugriff (PDF)

The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity

Anticancer research, 2017-09, Vol.37 (9), p.5249-5254

2017

Volltextzugriff (PDF)

Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer

Breast cancer (Tokyo, Japan), 2011-04, Vol.18 (2), p.120-123

2011

Volltextzugriff (PDF)

High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers

Breast cancer (Tokyo, Japan), 2012-04, Vol.19 (2), p.161-169

2012

Volltextzugriff (PDF)

Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma

Breast cancer research and treatment, 2007-03, Vol.101 (3), p.249-257

2007

Volltextzugriff (PDF)

A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis

World journal of surgical oncology, 2014-04, Vol.12 (1), p.84-84

2014

Volltextzugriff (PDF)

Differential impact of the expression of the androgen receptor by age in estrogen receptor–positive breast cancer

Cancer medicine (Malden, MA), 2013-12, Vol.2 (6), p.763-773

2013

Volltextzugriff (PDF)

Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literature

International journal of clinical and experimental pathology, 2014-01, Vol.7 (7), p.4371-4380

2014

Volltextzugriff (PDF)

No hypersensitive estrogen receptor-α mutation (K303R) in Japanese breast carcinomas

Breast cancer research and treatment, 2004-04, Vol.84 (3), p.289-292

2004

Volltextzugriff (PDF)

Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer

Breast cancer research and treatment, 2006-05, Vol.97 (2), p.199-203

2006

Volltextzugriff (PDF)

A case of ectopic breast carcinoma of the right axilla treated with neoadjuvant endocrine therapy

International cancer conference journal, 2015, Vol.4 (1), p.29-34

2015

Volltextzugriff (PDF)

No hypersensitive estrogen receptor-[alpha] mutation (K303R) in Japanese breast carcinomas

Breast cancer research and treatment, 2004-04, Vol.84 (3), p.289

2004

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular mechanisms regulating the hormone sensitivity of breast cancer

Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women

Vimentin as a poor prognostic factor for triple-negative breast cancer

Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer

HB‐EGF orchestrates the complex signals involved in triple‐negative and trastuzumab‐resistant breast cancer

Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer

The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy

Trastuzumab and breast cancer: developments and current status

Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer

Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer

Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer

Akt is frequently activated in HER2/neu‐positive breast cancers and associated with poor prognosis among hormone‐treated patients

The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer

The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity

Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer

High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers

Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma

A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis

Differential impact of the expression of the androgen receptor by age in estrogen receptor–positive breast cancer

Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literature

No hypersensitive estrogen receptor-α mutation (K303R) in Japanese breast carcinomas

Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer

A case of ectopic breast carcinoma of the right axilla treated with neoadjuvant endocrine therapy

No hypersensitive estrogen receptor-[alpha] mutation (K303R) in Japanese breast carcinomas

Aktive Filter

Suchergebnisse filtern